Yamaguchi T, Takahashi T, Yokota T, Kitamura K, Noguchi A, Kamiguchi M, Doi M, Ahn T, Sawai K, Yamane T
First Department of Surgery, Kyoto Prefectural University of Medicine, Japan.
Cancer. 1991 Aug 15;68(4):906-9. doi: 10.1002/1097-0142(19910815)68:4<906::aid-cncr2820680438>3.0.co;2-5.
The possibility that urinary pepsinogen I is a tumor marker of stomach cancer after total gastrectomy was examined. To decide the cutoff level of urinary pepsinogen I after total gastrectomy, urine samples from 15 patients who had undergone total gastrectomy for stomach cancer in the early or advanced stages and had been free from recurrence for more than 5 years were examined by pepsinogen I-specific radioimmunoassay. The mean concentration of urinary pepsinogen I was 17.5 +/- 7.4 ng/ml and the cutoff level of urinary pepsinogen after total gastrectomy was set at 32 ng/ml (mean + 2 SD). Twenty-two of 74 cases who had undergone total gastrectomy for stomach cancer were regarded as positive. And 20 of these 22 positive cases had definite clinical signs of recurrence of stomach cancer. There were only two false-positive cases. These results suggest that urinary pepsinogen I will be an useful tumor marker in detecting the recurrence of stomach cancer after total gastrectomy.
研究了胃蛋白酶原I是否为全胃切除术后胃癌的肿瘤标志物。为确定全胃切除术后胃蛋白酶原I的临界值,采用胃蛋白酶原I特异性放射免疫分析法检测了15例因早期或晚期胃癌接受全胃切除术且无复发超过5年的患者的尿液样本。胃蛋白酶原I的平均浓度为17.5±7.4 ng/ml,全胃切除术后胃蛋白酶原I的临界值设定为32 ng/ml(平均值+2标准差)。74例因胃癌接受全胃切除术的患者中有22例被视为阳性。这22例阳性病例中有20例有明确的胃癌复发临床体征。仅有2例假阳性病例。这些结果表明,胃蛋白酶原I将是检测全胃切除术后胃癌复发的有用肿瘤标志物。